Tetrahydrobiopterin cofactor activity of endothelial nitric oxide synthase

The term "Endothelial nitric oxide synthase cofactor activity" refers specifically to the **activity provided by cofactors—most notably tetrahydrobiopterin (BH4)—that are essential for the proper enzymatic function of endothelial nitric oxide synthase (eNOS)**. eNOS is an enzyme responsible for producing nitric oxide (NO), a critical molecule in vascular homeostasis, vasodilation, and cardiovascular protection. The presence and availability of its cofactors, especially BH4, are crucial because when BH4 is deficient or oxidized, eNOS becomes "uncoupled," leading it to produce superoxide instead of NO—a process implicated in endothelial dysfunction and various cardiovascular diseases[2][3][5]. **This entry does not refer to a discrete molecular target such as a receptor or enzyme but rather describes an enzymatic property dependent on the presence and status of specific cofactors**. Therefore, it should not be considered a canonical therapeutic target itself but rather an important functional aspect influencing the pharmacology and pathophysiology related to eNOS. > The regulation of NO production by eNOS is complex, but the pteridine cofactor tetrahydrobiopterin (BH₄) has emerged as a critical determinant... When BH₄ availability is limiting, eNOS no longer produces NO but instead generates superoxide... Thus, BH₄ represents a potential therapeutic target in the regulation of eNOS function in vascular disease.[2] > Diminished levels of BH₄ promote O₂·⁻ production by eNOS ("eNOS uncoupling")... Supplementation with BH₄ has been shown to correct eNOS dysfunction.[3] In summary: **"Endothelial nitric oxide synthase cofactor activity" describes an essential biochemical property required for normal enzyme action rather than being itself a druggable molecular entity. It should be flagged as incorrect if used as a standalone therapeutic target name.**

Other names

eNOS cofactor activityBH4-dependent eNOS functionEndothelial NOS cofactor function

Restoration or enhancement of NO production by increasing BH4 availability to eNOS[2][5]